EMA: Draft product-specific guidance ♬ [BE/BA News]
Dear all,
after the first 16 guidances EMA keeps going. The complete list with the respective end of consultation here.
after the first 16 guidances EMA keeps going. The complete list with the respective end of consultation here.
- Sunitinib published 2013-12-04
50 mg single dose cross-over in healthy subjects (fasting state), parent in plasma (achiral),
AR 80.00–125.00% for AUC72 and Cmax (HVD status not reviewed).
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- EMA: Draft product-specific guidance ♬Helmut 2013-12-06 01:54 [BE/BA News]